Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica
- Substances:Secukinumab
Italy- Participants:18–64 years · 65+ years
- Substances:Secukinumab
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Italy28 clinical trials in Bolzano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on various blood cancers, including Multiple Myeloma and Acute Lymphoblastic Leukemia. Studies evaluate innovative treatment combinations and novel therapeutic approaches.
Several trials are investigating targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into various solid cancers, including breast cancer, prostate cancer, and head and neck malignancies. Studies focus on targeted therapies and novel treatment combinations.
Trials explore personalized medicine approaches based on genetic markers and innovative drug combinations.
Clinical investigations of Polymyalgia Rheumatica and other autoimmune disorders, evaluating new biological treatments and therapeutic strategies.
Research focuses on improving treatment outcomes while minimizing steroid dependency.
Tell us about your condition – we search every trial in Europe and connect you with the right site.